Literature DB >> 7889311

Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.

J Jakubík1, S Tucek.   

Abstract

1. By measuring the binding of N-[3H-methyl]-scopolamine ([3H]-NMS) and of unlabelled subtype-specific muscarinic antagonists, two populations of muscarinic binding sites can be distinguished in the membranes of cardiac ventricles taken from 1-day-old chicks. One of them, corresponding to approximately 80% of [3H]-NMS binding sites, has higher affinities for AF-DX116 (pKi = 6.42) and methoctramine (pKi = 7.33); the rate of [3H]NMS dissociation from these sites is fast. The other population, corresponding to approximately 20% of [3H]-NMS binding sites, has lower affinities for AF-DX116 (pKi = 5.00) and methoctramine (pKi = 6.19); the rate of [3H]-NMS dissociation from these sites is slow. Both populations have high affinities for pirenzepine, but the affinity of the former (major) population is lower (pKi = 7.99) than that of the latter (minor) population (pKi = 10.14). 2. Since it has been shown earlier that two mRNAs for muscarinic receptors are expressed in the chick heart, one of them close to the genetically defined m2 and the other to the m4 subtype, we propose that the major population of binding sites with high affinities for AF-DX116 and methoctramine and the lower affinity for pirenzepine represents the M2-like receptors, while the minor population represents the M4-like receptors. 3. It proved possible to obtain isolated samples of either population by selectively protecting the M2-like sites with AF-DX116 and the M4-like sites with pirenzepine, and by inactivating the unprotected sites with benzilylcholine mustard. The properties of the isolated populations corresponded to those derived from the analysis of [3H]-NMS binding to the original mixed population.4 Alcuronium exerted positive allosteric action on the binding of [3H]-NMS both to the M2-like and the M4-like population and severely slowed down [3H]-NMS dissociation from them; its affinity for the M2-like sites was 3-10 times higher.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889311      PMCID: PMC1510540          DOI: 10.1111/j.1476-5381.1994.tb17170.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

Authors:  F J Ehlert
Journal:  Mol Pharmacol       Date:  1988-02       Impact factor: 4.436

Review 2.  Muscarinic receptor differentiation.

Authors:  F Mitchelson
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

3.  Muscarinic M1-receptors mediate the negative inotropic effect of methacholine in chicken but not in guinea-pig atria.

Authors:  R Lindmar; K Löffelholz
Journal:  Eur J Pharmacol       Date:  1987-07-23       Impact factor: 4.432

4.  Differences in antagonist affinities at muscarinic receptors in chick and guinea-pig.

Authors:  L K Choo; F Mitchelson; P Napier
Journal:  J Auton Pharmacol       Date:  1988-09

5.  Subtypes of muscarinic receptor on cholinergic nerves and atrial cells of chicken and guinea-pig hearts.

Authors:  D Jeck; R Lindmar; K Löffelholz; M Wanke
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

6.  The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.

Authors:  J H Brown; D Goldstein; S B Masters
Journal:  Mol Pharmacol       Date:  1985-05       Impact factor: 4.436

7.  Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.

Authors:  F J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

8.  Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.

Authors:  J Nedoma; S Tucek; A F Danilov; S A Shelkovnikov
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

9.  Modification of the binding properties of muscarinic receptors by gallamine.

Authors:  J M Stockton; N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

10.  Comparison of muscarinic receptor properties in hatched chick heart atrium and ventricle.

Authors:  S Sorota; L P Adam; A J Pappano
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

View more
  3 in total

1.  Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.

Authors:  M Lysíková; K Fuksová; T Elbert; J Jakubík; S Tucek
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.

Authors:  M Lysíková; Z Havlas; S Tucek
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

Review 3.  Pharmacology of myopia and potential role for intrinsic retinal circadian rhythms.

Authors:  Richard A Stone; Machelle T Pardue; P Michael Iuvone; Tejvir S Khurana
Journal:  Exp Eye Res       Date:  2013-01-08       Impact factor: 3.467

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.